Home

Burden

Read time: 4 min

Early intervention in schizophrenia may improve long-term outcome

Schizophrenia may not be as disabling if identified and treated early, resulting in many benefits...

Read time: 4 min

Improved cognition and insight into thinking: can we help these to be transferred to everyday life?

There’s ‘thinking’, and there’s ‘thinking about thinking’....

Read time: 4 min

Congress highlights

Pros and cons of persisting with antipsychotic treatment: assessing the evidence

Guidelines recommend that people with first-episode psychosis should where possible be maintained...

Read time: 4 min

Congress highlights

If one antipsychotic is good, why aren’t two better? Polypharmacy debated

Increased risk of side effects, reduced compliance, lack of rationale and, above all, no evidence...

Read time: 4 min

Congress highlights

Mortality excess in schizophrenia: can we close the gap?

People with first-episode psychosis who had no antipsychotic medication treatment had a five-year...

Alzheimer's Disease

Read time: 3 min

Agitation should be a focus in dementia

In the past, “agitation” in the context of the dementias referred to a wide range of...

Read time: 3 min

Right treatment at right time: Improving outcomes in first episode psychosis

Integrating evidence-based psychosocial and pharmacological treatments significantly improves the...

Read time: 2 min

THINC-it® cognition screening tool now clinically validated

In major depression, cognitive impairment – relative to matched healthy control individuals...

Read time: 4 min

Satellite symposium

Preventing schizophrenia relapse key to optimizing outcome

Sustained remission and good functional outcome depend on the interaction between factors we cannot...

Read time: 5 min

Satellite symposium

From mood to cognition: THINC-it, do it!

Cognitive symptoms and impairment in depression rank in importance alongside emotional and physical...

Alzheimer's Disease

Read time: 4 min

Congress highlights

Moves towards better management of agitation

Ninety percent of people with Alzheimer’s experience at least one clinically significant...

Read time: 1 min

Though humbled by brain complexity, we still make progress - Interview with Prof Celso Arango

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country